Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose cyclosporine A in hepatitis C-positive renal transplant recipients
2011-002267-26Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in hepatitis C virus infection and Kidney allograft status (RTx), sponsored by Medical University of Vienna. Primary endpoint: HCV-RNA. Started Mar 2012; status: completed.
02
Drugs
cyclosporine
03
Conditions
hepatitis C virus infectionKidney allograft status (RTx)
Beyond the preview
Go deeper on 2011-002267-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002267-26.